Clinical Trial Update: A Study to Systematically Assess the Efficacy and Safety of Intravenous Albumin Infusions in Severe POTS [Phase 3]

View source ↗

Summary

A Phase 3 study evaluating the efficacy and safety of intravenous albumin infusions in severe Postural Orthostatic Tachycardia Syndrome has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postural Orthostatic Tachycardia Syndrome

Drugs mentioned

• intravenous albumin (albumin)

Snippet

Sponsor: University of Alberta | Conditions: Postural Orthostatic Tachycardia Syndrome | Phase 3 | Status: WITHDRAWN